glp 1 drugs adverse effects A Retrospective Comparative Analysis of Cutaneous Reactions in GLP-1 Agonist Therapies - JDDonline glp 1 drug side effects

Pharmaceutical companies are working on innovative formulations, improved bioavailability, combination treatments, and modes of administration

Glucagon receptor activation: Increases hepatic glucose output (relevant in fasted states), stimulates lipolysis in adipose tissue, and raises basal metabolic rate through thermogenic mechanisms

Expanding cell clusters through recruitment of cell proliferation could help maintain normal blood glucose levels, potentially compensating for cell loss or dysfunction in diabetes (Sjholm, 1996)

[DOI] [PMC free article] [PubMed] [Google Scholar] 2.Theodorakis N., Nikolaou M

Measuring biomarkers like fasting insulin, C-peptide, and inflammatory markers (hsCRP) can provide context for whether your metabolic profile aligns with conditions where prescription GLP-1 therapy has the strongest clinical evidence

While there are limitations, the promise of improved diabetes management, cardiovascular benefits, and new formulations places GLP-1 agonists at the forefront of diabetes care